Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01149876 · ClinicalTrials.gov registry record · Phase 4
Study to Evaluate the Effect of a Nu Skin Product and Device for Brown Spots
A Phase 4 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
NCT01149876: Completed Phase 4 study, sponsored by Massachusetts General Hospital.
NCT01149876 is a Phase 4 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01149876, a Phase 4 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a topical Nu Skin product with or without a galvanic spa device improves brown spots on the face. The Nu Skin product will be compared to an over the counter moisturizer and tretinoin cream.
Interventions
- OTHER Nu Skin Product
- OTHER Cosmetic instrument
- DRUG Tretinoin cream 0.05
- OTHER CeraVe moisturizer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2010-06 |
| Est. Completion | 2011-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01149876
The ClinicalTrials.gov registry entry for NCT01149876 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Nu Skin Product is the first listed.
NCT01149876 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01149876 about?
NCT01149876 is a clinical study titled "Study to Evaluate the Effect of a Nu Skin Product and Device for Brown Spots". The purpose of this study is to determine whether a topical Nu Skin product with or without a galvanic spa device improves brown spots on the face. The Nu Skin product will be compared to an over the counter moisturizer and tretinoin cream.
What is the current status of trial NCT01149876?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2010-06. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01149876?
The interventions under investigation include: Nu Skin Product (OTHER), Cosmetic instrument (OTHER), Tretinoin cream 0.05 (DRUG), CeraVe moisturizer (OTHER).
Who is sponsoring clinical trial NCT01149876?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.